Analysis and Perspectives

Apr 03, 2023

DAYBUE (trofinetide) by Acadia Pharmaceuticals & Neuren Pharmaceuticals became the first & only FDA-approved drug for Rett syndrome treatment.

Mar 31, 2023

Cell therapies open doors for advanced peripheral artery disease treatment and are discussed comprehensively as novel regenerative medicine.

Mar 29, 2023

In recent years, Probiotics and prebiotics products have gained intense development and attention from the scientific, researchers, and healthcare giants due to their beneficial roles in maintaining human health. Several clinical studies have demonstrated a positive effect of probiotics on gastrointestinal diseases...

Mar 27, 2023

SHTG and FCS treatment market to evolve with the launch of ApoC-III inhibiting drugs, Olezarsen (Ionis) and ARO-APOC3 (Arrowhead). Clinical…

Mar 24, 2023

With increasing MedTech companies, their products, & regulatory approvals, we can see increased adoption of robotics in surgery.

Mar 22, 2023

Orthopedic Implants Market is expected to grow at an immense pace. Companies are working to develop new implants to fulfill the demand

Mar 17, 2023

Immuno-oncology (I-O) therapeutics, despite yielding effective outcomes, remain associated with a risk of failure & adverse side effects.

Mar 15, 2023

The applications of Artificial Intelligence (AI) In Drug Commercialization is growing at an unprecedented rate. It provides several benefits

Mar 13, 2023

Owning to evolution of genomic profiling technologies, cancer biomarkers are becoming increasingly relevant in management of cancer patients.

Mar 08, 2023

Burn is one of the most severe and rapidly growing burdens worldwide, leading to a very high number of mortality and morbidity yearly. It can have intense physical, socioeconomic, and psychological consequences on the person and their family. As per the latest assessment by DelveInsight, incident cases of burns req...